MMS · Maximus, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture- non-GAAP | $6.14 | For the Nine Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDA (Non-GAAP) non-GAAP | 192.33M | For the Three Months Ended June 30, 2026 filing | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net income 103.59M
+34.57M Provision for income taxes
+23.88M Interest expense
-608K Other (income)/expense, net
+20.19M Amortization of intangible assets
-1.16M Divestiture-related charges/(gains)
+11.87M Depreciation and amortization of property, equipment, and capitalized software
+0K Capitalized software impairment charges
= Adjusted EBITDA (Non-GAAP) 192.33M
|
|||
| Adjusted EBITDA margin (Non-GAAP) non-GAAP | 14% | For the Nine Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted net income excluding amortization of intangible assets and divestiture-related adjustme non-GAAP | 117.62M | For the Three Months Ended June 30, 2026 filing | — |
|
|
|||
| contracts pending (awarded but unsigned) | 1.35B | Year-to-date at June 30, 2026 | — |
| DSO | 98 | at June 30, 2026 | — |
| free cash flow non-GAAP | $137M | Q3 FY2026 | — |
|
|
|||
| opportunities tracking | 45.1B | at June 30, 2026 | — |
| proposals in preparation | 2.42B | at June 30, 2026 | — |
| proposals pending | 2.86B | at June 30, 2026 | — |
| year-to-date signed contract awards | 1.25B | Year-to-date at June 30, 2026 | — |
| contracts pending | $322M | Six months ended March 31, 2026 | — |
| opportunities we are tracking | $50.7B | At March 31, 2026 | — |
| sales pipeline | $56.8B | At March 31, 2026 | — |
| signed contract awards year-to-date | $913M | Six months ended March 31, 2026 | — |
| Free cash flow (Non-GAAP) non-GAAP | -250.67M | For the Three Months Ended December 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MMS
this stock
Maximus, Inc.
|
$3.13B | -30.8% | -2.4% | 8.9 | 5.9% |
|
CTAS
Cintas Corp
|
$81.71B | +8.6% | +6.4% | 41.6 | 2.6% |
|
RELX
Relx PLC
|
$63.64B | -9.6% | — | — | 0.3% |
|
TRI
Thomson Reuters Corp /Can/
|
$46.02B | -19.5% | — | — | 2.9% |
|
CPRT
Copart Inc
|
$30.54B | -15.7% | +24.7% | 20.6 | 4.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MMS | +2.6% | -0.8% | -22.7% | -0.8% | -30.8% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +2.2% | -3.8% | -36.1% | -3.8% | -43.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.